Are you ready to begin care at the Drake Institute?
Get Started >>Do you need more information before you begin?
Ask Us >>News Videos - Drake Institute is the News
View Videos>>Audio FAQ - Learn about ADD from Dr. Velkoff, MD
Learn More >>Listen to Radio Interviews with Dr. David Velkoff, MD
Listen Now >>
Dea Press Release on Methylphenidate (summarized)
Methylphenidate (MPH), most commonly known as Ritalin, ranks in the top 10 of most frequently reported controlled pharmaceuticals stolen from licensed handlers.
Abuse of MPH can lead to marked tolerance and severe psychic dependence.
Organized drug trafficking groups in a number of states have utilized various schemes to obtain MPH for resale on the illicit market.
MPH is abused by diverse segments of the population from health care professions and children to street addicts.
A significant number of children and adolescents are diverting or abusing MPH medication intended for the treatment of ADHD.
In 1994, a national high school survey (Monitoring the Future) indicated that there are more seniors in the U.S. abusing Ritalin than are using legitimately prescribed Ritalin.
Students are giving and selling their medication to classmates who are crushing and snorting the powder like cocaine. In March of 1995, two deaths in Mississippi and Virginia were associated with this activity.
DAWN statistics on estimated emergency room mentions indicate that there were 271 mentions in 1990, 657 mentions in 1991, 1,044 mentions in 1992 and 725 in 1993 (of which 28% to 40% were associated with abuse for dependence or psychological effects). The number of mentions for MPH was significantly greater than mentions for Schedule III stimulants (6 mentions in 1992 and 1 mention in 1993 for all Schedule III stimulants).
The U.S. manufactures and consumes 5-times more MPH than the rest of the world combined.
MPH is aggregate production quota has increased almost 6-fold since 1990.Every indicator available, including scientific abuse liability studies, actual abuse, paucity of scientific studies on possible adverse effects associated with long-term use of stimulants, divergent prescribing practices of U.S. physicians and lack of concurrent medical treatment and follow-up, urge greater caution and more restrictive use of MPH.
October 20, 1995
Treatment of Attention Deficit Disorder and Attention Deficit Hyperactivity Disorders for Children and Adults
Learn more about the Drake Institute's treatment for ADD / ADHD
Neurofeedback, Drugs, Treatments & Related Information
ADD/ADHD • Autism
• Language Disorders • Stress
Disorders
Copyright © 2007 - The Drake Institute of
Behavioral Medicine & Medical Associates
